Clinical trial
A One Year Double-blind Trial to Investigate the Efficacy and Safety of…
NCT00279747 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00279747 |
|---|---|
| Title | A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA) |
| Official title | A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension 0.25mg/kg and 0.125 mg/kg Administered Once Daily in Comparison to Naproxen Oral Suspension 5mg/kg Administered Twice Daily in Children With Juvenile Rheumatoid Arthritis. |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arthritis, Juvenile Rheumatoid |
| Intervention type | Drug |
| Interventions | meloxicam 0.25 mg/kg, meloxicam 0.125 mg/kg, naproxen 10 mg/kg |
| Enrollment | 226 |
| Start date | Sep 1, 2000 |
| Primary completion | Jan 1, 2003 |
| Completion | Jan 1, 2003 |
| First posted | Jan 20, 2006 |
| Last update posted | Nov 1, 2013 |
| Countries | Austria, Belgium, France, Germany, Italy, Russia, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: